Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion type Assertion NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_head.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion description "[The MEF2A mutations may account for up to 1.93% of the disease population; thus, genetic testing based on mutational analysis of MEF2A may soon be available for many coronary artery disease/myocardial infarction patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_provenance.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion evidence source_evidence_literature NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_provenance.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion SIO_000772 15861005 NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_provenance.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion wasDerivedFrom befree-2016 NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_provenance.
- NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_assertion wasGeneratedBy ECO_0000203 NP492142.RA0eP-q75k5fd-EEwB47yP2qk7NSDcqR9PdKv8_Tjctw4130_provenance.